Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy

An international Clinical Outcomes Group consisting of clinicians, scientists, patient advocacy groups, and industries identified a need for a scale to measure motor performance of the upper limb. We report the steps leading to the development of the Performance of the Upper Limb (PUL), a tool specifically designed for assessing upper limb function in ambulant and non‐ambulant patients with Duchenne muscular dystrophy (DMD).

[1]  R. Abresch,et al.  Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[2]  G. van Ommen,et al.  Systemic administration of PRO051 in Duchenne's muscular dystrophy. , 2011, The New England journal of medicine.

[3]  R. H. Jebsen,et al.  An objective and standardized test of hand function. , 1969, Archives of physical medicine and rehabilitation.

[4]  A. Mayhew,et al.  Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy , 2011, Developmental medicine and child neurology.

[5]  Jay J. Han,et al.  The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations , 2010, Muscle & nerve.

[6]  S. Gasperini,et al.  Functional changes in Duchenne muscular dystrophy , 2011, Neurology.

[7]  M. Brooke,et al.  Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.

[8]  Graeme Hutcheson,et al.  Rasch Models for Measurement , 2011 .

[9]  E. Mazzone,et al.  A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy , 2012, Developmental medicine and child neurology.

[10]  T. Voit,et al.  Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients , 2013, Neuromuscular Disorders.

[11]  Jay J. Han,et al.  The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy , 2010, Muscle & nerve.

[12]  R. Finkel,et al.  Assessing upper limb function in nonambulant SMA patients: Development of a new module , 2011, Neuromuscular Disorders.

[13]  E. Mazzone,et al.  International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy , 2012, Neuromuscular Disorders.

[14]  G. Comi,et al.  24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy , 2013, PloS one.

[15]  A. Zupan Assessment of the functional abilities of the upper limbs in patients with neuromuscular diseases. , 1996, Disability and rehabilitation.

[16]  J. Bourke,et al.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study , 2011, The Lancet.

[17]  Ruzena Bajcsy,et al.  Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases , 2012, PloS one.

[18]  Francesco Muntoni,et al.  Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. , 2012, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[19]  Jay J. Han,et al.  Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences , 2012, PLoS currents.

[20]  M. Main,et al.  Reliability of the North Star Ambulatory Assessment in a multicentric setting , 2009, Neuromuscular Disorders.

[21]  J. Fermanian,et al.  Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure , 2010, Developmental medicine and child neurology.

[22]  Jay J. Han,et al.  The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used , 2013, Muscle & nerve.

[23]  Marika Pane,et al.  North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy , 2010, Neuromuscular Disorders.